[Ip-health] Merck pharmagate protest in London
mkamalyanni at Oxfam.org.uk
Wed Feb 5 04:56:58 PST 2014
When will Pharma know that the problem is not activists nor governments.
Their problem is their business model which is fundamentally flawed and
not suitable for 21 century!
Best wishes for more Sane, Just and Peaceful world in 2014
Dr. Mohga M Kamal-Yanni
Senior health & HIV policy advisor, Oxfam GB
John Smith Drive, Oxford, OX4 2JY, UK
UK Mobile + 44 (0)777 62 55 884
Follow me @MohgaKamalYanni
From: Diarmaid McDonald <Diarmaid at stopaids.org.uk>
To: "'ip-health at lists.keionline.org'" <ip-health at lists.keionline.org>,
"'ip-health at lists.essential.org'" <ip-health at lists.essential.org>
Date: 05/02/2014 12:28
Subject: [Ip-health] Merck pharmagate protest in London
Sent by: "Ip-health" <ip-health-bounces at lists.keionline.org>
AIDS Activists say Merck walking all over South Africans for profit
Wednesday 5th February 2013
Activists wrapped in South African flags lay on the ground at the entrance
to the London offices of Merck today, demanding the multinational pharma
company drop their opposition to South Africa's plans to improve access to
Forcing staff to step over them, and past a banner reading, "Merck - ready
to walk all over South African's to turn a profit", the activists say they
represented the millions of people living in South Africa who are
prevented from accessing medicines because of high prices.
A strategy document, leaked last month, revealed Merck as the ringleaders
of a secret big-money plot to derail a South African government plan to
overhaul the nation's patent laws. The plot - largely financed with big
pharma cash from the US - detailed a sophisticated series of actions
designed to resemble a political campaign aimed at stopping the reforms
from going through.
Drug companies have described the battle to block the reforms as "ground
zero" in their global battle to tighten intellectual property law. Across
the developing world tighter IP laws have led to higher prices and
worsening health outcomes, whereas the pro-health reforms opposed by big
pharma have reduced prices and increased access in places like India,
Thailand and South America.
Campaigners say the current laws massively prioritise patents and profits
over health and prevent millions of people in South African from accessing
affordable treatment. Antibiotic Linezolid, for example, is priced at £37
per pill in South Africa, but is available for just £1.37 in India.
Diarmaid McDonald from STOPAIDS who took part in the demonstration said,
"Merck and over a dozen other big pharma companies tried to hijack the
democratic process in South Africa by spending hundreds of thousands of
dollars on a myth-pedalling campaign to protect their profits at the cost
of the lives of people who need access to affordable medicines.
"We're here to demand that they drop this attack on South African's right
to health. We call on the South African government to press ahead with
these lifesaving reforms. Merck and big pharma must stop trying to walk
all over South Africans in order to turn a profit.
"We also call on the UK government to defend South Africa's right to
reform their laws for the benefit of their people. This is a perfectly
legal move, well within rules agreed by the WHO and WTO, designed to
increase access to medicines. With DFID pulling out of South Africa it is
even more important the UK defends South Africa when it tries to make
these pro-health reforms."
South Africa does not currently review patent applications, leading to
more patents being granted there than in either the US or EU. In 2008
alone, 2442 pharmaceutical patents were granted - almost ten times the
number granted by Brazil over five years. Many companies make small
changes to their drugs and file new patents in order to maintain their
South African monopoly in a practice known as 'ever-greening'. By
reforming the law South Africa can increase access to affordable medicines
in the country where over 5 million people are living with HIV and costs
of 2nd and 3rd line treatments which are increasingly needed are still
· STOPAIDS is a network of 80 UK agencies working since 1986 to
secure an effective global response to HIV and AIDS.
· The leaked Pharmagate plot documents can be read here:
And here: http://keionline.org/sites/default/files/merck-email.pdf
· The 'Fix the Patent Laws<http://www.fixthepatentlaws.org/>'
campaign in South Africa is run by MSF and the Treatment Action Campaign
and states: South Africa's current patent laws put the rights of
patent-holders before the rights of patients. The law includes all the
worst parts from the international TRIPS agreement on trade and
intellectual property, but does not include the parts that we can use to
make medicines more affordable. The campaign aims to secure reforms so
South Africa fully utilises legal flexibilities in the agreement to
improve access to medicines there.
Contact: Diarmaid McDonald 07894455781
00 44 (0) 20 7324 4785
We've rebranded! STOPAIDS brings together our two previous identities -
the UK Consortium on AIDS and International Development and the Stop AIDS
As part of its factsheet series, STOPAIDS has partnered with two of its
members, WaterAid<http://www.wateraid.org/uk/> and CAFOD<
http://www.cafod.org.uk/>, to explore the connections between water,
sanitation, hygiene (WASH), HIV and AIDS, and provide recommendations on
how HIV interventions can integrate WASH into their programming. Download
the factsheet here<
28 Charles Square
London N1 6HT
Company Number: 2589198; Charity Number: 1113204
This email is confidential to the addressee and may be legally privileged.
If you have received it in error, please delete if from your computer.
This email has been scanned by the Purple Matrix
Email Security System.
Ip-health mailing list
Ip-health at lists.keionline.org
Oxfam works with others to overcome poverty and suffering.
Oxfam GB is a member of Oxfam International and a company limited by guarantee registered in England No. 612172.
Registered office: Oxfam House, John Smith Drive, Cowley, Oxford, OX4 2JY.
A registered charity in England and Wales (no 202918) and Scotland (SC 039042)
More information about the Ip-health